Dronedarone Reduces CV Hospitalization, Death in Patients With AF With, Without T2D
Researchers sought to assess the safety and efficacy of dronedarone therapy for patients with atrial fibrillation and diabetes.
Sheila Jacobs
Contributing Writer https://www.endocrinologyadvisor.com
Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.
